| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.1M | -64.2% |
| SG&A Expense | $15.0M | -33.3% |
| Operating Income | -$26.1M | +51.2% |
| Income Tax | $5K | +171.4% |
| Net Income | -$26.3M | -91.4% |
| EPS (Basic) | -$8.08 | — |
| EPS (Diluted) | -$8.08 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | — |
| Current Assets | $1.5M | -34.8% |
| Total Assets | $4.4M | +26.6% |
| Current Liabilities | $7.1M | -21.8% |
| Total Liabilities | $12.6M | +24.5% |
| Stockholders' Equity | -$8.2M | -23.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.3M | -2.7% |
| Capital Expenditures | $64K | — |
| Investing Cash Flow | -$64K | — |
| Financing Cash Flow | $11.7M | -4.6% |
| Free Cash Flow | -$12.4M | — |